1. Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School; Boston Massachusetts
2. FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat; Université Paris-Diderot, INSERM U-1148; Paris France
3. NHLI, Imperial College; Royal Brompton Hospital; London United Kingdom
4. Utah Foundation for Biomedical Research, and Utah Lipid Center; Salt Lake City
5. Office of Health Promotion and Disease Prevention, Department of Medicine; Emory University School of Medicine; Atlanta Georgia
6. Department of Medicine; University of Maryland School of Medicine; Baltimore
7. Montreal Heart Institute; Université de Montréal; Québec Canada
8. Amarin Pharma Inc.; Bedminster New Jersey
9. TIMI Study Group, Cardiovascular Division, Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts
10. Albireo Pharma; Boston Massachusetts
11. KemPharm, Inc., Celebration; Florida
12. Department of Medicine, Baylor College of Medicine, and Center for Cardiovascular Disease Prevention; Methodist DeBakey Heart and Vascular Center; Houston Texas